Neural hormonal regulation of exocrine pancreatic secretion

Pancreatology

Volumn 1, Issue 4, 2001, Pages 320-335

  Chey, William Y ^a   Chang, Ta Min ^a  

^a Rochester Institute for Digestive Diseases and Sciences   (United States)

Author keywords

Acetylcholine; CCK releasing peptide; Cholecystokinin; Feedback regulation; Neuropeptides; Secretin; Secretin releasing peptide; Serotonin; Vagal afferent pathway

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; PANCREAS HORMONE;

ANIMAL; HUMAN; INNERVATION; METABOLISM; PANCREAS; PHYSIOLOGY; REVIEW; SECRETION;

ANIMALS; HUMANS; NEUROTRANSMITTER AGENTS; PANCREAS; PANCREATIC HORMONES;

EID: 0035553960     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000055831     Document Type: Conference Paper

References (145)

1. Babkin BP: Die äussere Sekretion der Verdauungsdrüsen. Berlin, Springer, 1914.
2. Babkin, BP: Die sekretorische Tätigkeit der Verdauungsdrüsen; in Bethe et al. (ed): Handbuch der normalen und pathologischen Physiologie. Berlin, Springer, 1927, vol 3, pp 689-818.
3. Babkin BP: Pavlov: A Biography. Chicago, University of Chicago Press, 1949.
4. Bayliss M, Starling EH: Mechanism of pancreatic secretion. J Physiol Lond 1902;28:325-353.
5. Mutt V, Magnunson S, Jorpes JE, Dahl E: Structure of porcine secretin. I. Biochemistry 1965;4:2358-2362.
6. Jorpes JE, Mutt V: Cholecystokinin and pancreozymin, one single hormone? Acta Physiol Scand 1966;66:196-202.
7. Gregory RA, Tracy HJ: The preparation and properties of gastrin. J Physiol Lond 1961;156: 523-543.
8. Green GM, Lyman RL: Feedback regulation of pancreatic enzyme as a mechanism for trypsin inhibitor-induced hypersecretion in rats. Proc Soc Exp Biol Med 1972;140:6-12.
9. Chey WY, Lee YH, Hendricks JF, Rhodes RA, Tai HH: Plasma secretin concentration in fasting and postprandial in man. Am J Dig Dis 1978;23:981-988.
10. Schaffalitzky de Muckadel OB, Fahrenkrug J: Secretion pattern of secretin in man: Regulation of gastric acid. Gut 1978;19:812-828.
11. Chey WY, Kim MS, Lee KY, Chang TM: Effect of rabbit antisecretin serum on postprandial pancreatic secretion in dog. Gastroenterology 1979;77:1268-1275.
12. Chang TM, Chey WY: Radioimmunoassay of secretin: A critical review. Dig Dis Sci 1980;25: 529-552.
13. Chey Y, Chang TM: Secretin; in Makhlouf G (ed): Handbook of Physiology; Section 6: The Gastrointestinal System. Bethesda, American Physiological Society, 1989, vol 2, pp 359-402.
14. Rehfeld JF: Cholecystokinin; in Makhlouf G (ed): Handbook of Physiology; Section 6: The Gastrointestinal System. Bethesda, American Physiological Society, 1989, vol 2, pp 337-358.
15. Jo YH, Lee KY, Chang TM, Chey WY: Role of cholecystokinin in pancreatic bicarbonate secretion in dogs. Pancreas 1991;6:197-201.
16. Hildebrand P, Beglinger C, Gyr K, Jansen JBMJ, Rovati L, Zuercher M, Lamers CBHW, Setnikar I, Stalder GA: Effect of a cholecystokinin receptor antagonist on intestinal panse of pancreatic biliary responses in man. J Clin Invest 1990;85:640-646.
17. You CH, Rominger JM, Chey WY: Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiological dose of secretin in humans. Gastroenterology 1983;85:40-45.
18. Chey WY, Lee KY, Chang TM, Chen YF, Millikan L: Potentiation effect of secretin on cholecystokinin stimulated pancreatic secretion in dogs. Am J Physiol 1984;246:G248-G252.
19. Polak JM: Endocrine cells of the gut; in Makhlouf G (ed): Handbook of Physiology; Section 6: The Gastrointestinal System. Bethesda, American Physiological Society, vol 2, pp 79-96.
20. Baca I, Feurle GE, Schwab A, Mittmann U, Knauf W, Lehnert T: Effect of neurotensin on exocrine pancreatic secretion in dogs. Digestion 1982;23:174-183.
21. Feurle GE, Hofmann G, Carraway R, Baca I: Reproduction of postprandial neurotensin plasma levels by intravenous neurotensin and the effect of neurotensin on exocrine pancreatic secretion in humans. Pancreas 1986;1:329-334.
22. Feurle GE, Baca I, Knauf W: Atropine depresses release of neurotensin and its effect on the exocrine pancreas. Regul Pept 1982;4:75-82.
23. Konturek SJ, Jaworek J, Cieszkowski M, Pawlik W, Kania J, Bloom SR: Comparison of effects of neurotensin and fat on pancreatic stimulation in dogs. Am J Physiol 1982;244: G590-G598.
24. Gullo L: The effect of neurotensin on pure pancreatic in man. Scand J Gastroenterol 1987;22: 343-348.
25. Khalil T, Fujimura M, Greeley GH, Towsend CM, Thompson JC: Neurotensin stimulates pancreatic exocrine secretion in rats. Regul Pept 1986;15:279-284.
26. Nustede R, Schmidt WE, Kohler H, Folsch UR, Schafmayer A: Role of neurotensin in the regulation of exocrine pancreatic secretion in dogs. Regul Pept 1993;44:25-32.
27. Baca I, Feurle GE, Haas M, Mernitz T: Interaction of neurotensin, cholecystokinin, and secretin in the stimulation on exocrine pancreas in the dog. Gastroenterology 1983;84:556-561.
28. Nagain C, Chariot J, Roze C: Mechanism of neurotensin stimulation of external pancreatic secretion in the rat. Pancreas 1993;8:346-353.
29. Feurle GE, Reinecke M: Neurotensin interacts with carbachol, secretin, and caerulein in the stimulation of the exocrine pancreas of the rat in vitro. Regul Pept 1983;7:137-143.
30. Feurle GE, Niestroj S: The site of action of neurotensin in the rat pancreas. Pancreas 1991;6: 202-207.
31. Lee KY, Zhou L, Ren XS, Chang TM, Chey WY: An important role of endogenous insulin on exocrine pancreatic secretion in rats. Am J Physiol 1990;258:G268-G274.
32. Van Trappen G, Peeters TL: Motilin; in Makhlouf G (ed): Handbook of Physiology; Section 6: The Gastrointestinal System. Bethesda, American Physiological Society, 1989, vol 2, pp 545-558.
33. DiMagno EP, Hendricks JC, Go VL, Dozois R: Relationships among canine fasting pancreatic and biliary secretions, pancreatic duct pressures and duodenal phase III motor activity - Boldyreff revisited. Dig Dis Sci 1979;24:689-693.
34. Van Trappen GR, Peeters TL, Janssen J: The secretory component of the interdigestive migrating motor complex in man. Scand J Gastroenterol 1979;14:663-667.
35. Lee KY, Shiratori K, Chen YF, Chang TM, Chey WY: A hormonal mechanism for the interdigestive pancreatic secretion in dogs. Am J Physiol 1986;251:G759-G764.
36. Lee KY, Chang TM, Chey WY: Effect of rabbit antimotilin serum on myelectric activity and plasma motilin concentration in fasting dog. Am J Physiol 1983;245:G547-G553.
37. Boden G, Sivitz MC, Owen OE, Essa-Koumar N, Landor JH: Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 1975;90:163-164.
38. Schlegel W, Raptis S, Harvey RF, Oliver JM, Pfeiffer EF: Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet 1977;ii:166-168.
39. Larsson LI: Evidence of anterograde transport of secretory granules in processes of gastric paracrine (somatostatin) cells. Histochemistry 1984;80:323-326.
40. Konturek SJ, Meyers CA, Kwiecien N, Obutowicz W, Tasler J, Olesky J, Kopp B, Coy DH, Schally AV: Effect of human pancreatic polypeptide and its C-terminal hexapeptide on pancreatic secretion in man and in the dog. Scand J Gastroenterol 1982;17:395-399.
41. Lin TM, Evans DC, Chance RE, Spray GF: Bovine pancreatic peptide: Action on gastric and pancreatic secretion in dogs. Am J Physiol 1977;232:E311-E315.
42. Taylor IL, Solomon TE, Walsh JH, Grossman MI: Pancreatic polypeptide metabolism and effect on pancreatic secretion in dogs. Gastroenterology 1979;76:524-528.
43. Chen MH, Joffe SN, Magee DF, Murphy RF, Naruse S: Cyclic changes of plasma pancreatic polypeptide and pancreatic secretion in fasting dogs. J Physiol Lond 1983;341:453-461.
44. Keane FB, DiMagno EP, Dozois RR, Go VLW: Relationship among canine interdigestive exocrine pancreatic and biliary flow, duodenal motor activity, plasma pancreatic polypeptide, and motilin. Gastroenterology 1980; 78:310-316.
45. Shiratori K, Lee KY, Chan TM, Jo YH, Coy DH, Chey WY: Roles of pancreatic polypeptide in the regulation of pancreatic exocrine secretion in dogs. Am J Physiol 1988;255: G535-G541.
46. Hosotani R, Inoue K, Kogire M, Tatemoto K, Mutt V, Suzuki T, Rayford PL, Tobe T: Effect of natural peptide YY on pancreatic secretion and cholecystokinin release in conscious dogs. Dig Dis Sci 1989;34:468-473.
47. Konturek SJ, Bilski J, Pawlick W, Tasler J, Domshke W: Adrenergic pathway in the inhibition of pancreatic secretion by peptide YY in dogs. Gastroenterology 1988;94:286-273.
48. Greeley GH Jr, Hashimoto T, Izukura M, Gomez G, Jang J, Hill F, Lluis F, Thompson JC: A comparison of intraduodenally and intracolonically administered nutrients on the release of peptide YY in the dog. Endocrinology 1989;125:1761-1765.
49. Adian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of new gut hormone, PYY. Gastroenterology 1985;98:1070-1077.
50. Jin H, Cai L, Lee KY, Chang TM, Li P, Wagner D, Chey WY: A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterology 1993;105:208-215.
51. Issoual D, Berger Z, Laugier R: CCK and PYY do not participate in the delayed inhibition of pancreatic secretion, after stimulation by duodenal oleic acid infusion. Regul Pept 1991;36: 45-57.
52. Putman WS, Liddle RA, William JA: Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide. Am J Physiol 1989;256:G698-G703.
53. Masuda M, Tomita H, Okubo K, Miyasaka K: Vagal efferent nerve-dependent inhibitory action of pancreatic polypeptide and peptide YY in conscious rats: Comparison with somatostatin. J Auton Nerv Syst 1994;50:131-138.
54. Anini Y, Jarrousse C, Chariot J, Nagain C, Yanaihara N, Sasaki K, Bernad N, Le Nguyen D, Bataille D, Roze C: Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats. Pancreas 2000;20:348-360.
55. Bilski J, Hladij M, Jaworek J, Konturek SJ, Varga G: Effect of peptide YY on dog and rat pancreatic secretion in vivo and in vitro. Int J Pancreatol 1988;3:309-321.
56. Huang SC, Tsai MF: Receptor for peptide YY and neuropeptide Y on guinea pig pancreatic acini. Peptides 1994;15:405-410.
57. Pernow J, Saria A, Lundberg JM: Mechanism underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control. Acta Physiol Scand 1986;126:239-249.
58. Wahlestedt C, Yanaihara N, Hakanson JR: Efficiency for different pre- and postjunctional receptors for neuropeptide Y and related peptides. Regul Pept 1986;13:307-318.
59. Brodish RJ, Kuvshinoff BW, McFadden DW, Fink AS: Adrenergic pathways do not mediate peptide YY-induced inhibition of pancreatic exocrine secretion. Pancreas 1995;10:187-193.
60. Brodish TJ, Kuvshinoff BW, Fink AS, McFadden DW: Peptide YY inhibits pancreatic secretion via cholinergic pathways. J Surg Res 1993; 55:103-108.
61. Grandt D, Siewert J, Sieburg B, al Tai O, Schimiczek M, Goebell H, Layer P, Eysselein VE, Reeve JR, Muller MK: Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors. Pancreas 1995;10:180-186.
62. Gershon MD: The enteric nervous system. Annu Rev Neurosci 1981;4:227-272.
63. Li Y, Hao Y, Zhu J, Owyang C: Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology 2000;118:1197-1207.
64. Li JP, Chang TM, Chey WY: Roles of 5-HT receptors in the release and action of secretin on pancreatic secretion in rats. Am J Physiol Gastrointest Liver Physiol 2001;280:G595-G602.
65. Kirchgessner AL, Gershon MD: Presynaptic inhibition by serotonin of nerve-mediated secretion of pancreatic amylase. Am J Physiol 1995;268:G339-G345.
66. Kirchgessner AL, Gershon MD: Innervation of the pancreas by neurons in the gut. J Neurosci 1990;10:1626-1642.
67. 1A receptors in the nervous systems of the bowel and pancreas. J Comp Neurol 1996;364:439-455.
68. Koveary SB, McEvoy RC, Azmitia EC: Specific uptake of tritiated serotonin in the adult rat pancreas: Evidence for the presence of serotonergic fibers. Am J Anat 1980;159:361-368.
69. Bozkurt T, Adler G, Koop I, Arnold R: Effect of atropine on intestinal phase of pancreatic secretion in man. Digestion 1988;41:108-115.
70. Chey WY, Kim MS, Lee KY: Influence of the vagus nerve on release and action of secretin in dog. J Physiol Lond 1979;293:453-446.
71. Konturek SJ, Tasler J, Oftulowicz W: Effect of atropine on pancreatic responses to endogenous and exogenous cholecystokinin. Dig Dis Sci 1972;17:911-917.
72. Evans RL, Ashton N, Elliott AC, Green R, Argent BE: Interaction between secretin and acetylcholine in the regulation of fluid secretion by isolated rat pancreatic ducts. J Physiol Lond 1996;496:265-273.
73. Louie DS, Owyang C: Muscarinic receptor subtypes on rat pancreatic acini: Secretion and binding studies. Am J Physiol 1986;251:G275-G279.
74. You CH, Chey WY: Atropine abolishes the potentiation effect of secretin and cholecystokinin-octapeptide on exocrine pancreatic secretion in humans. Pancreas 1988;3:99-103.
75. Hopman WPW, Jansen JBMJ, Lamers CBHW: Effect of atropine on the plasma cholecytostokinin response to intraduodenal fat in man. Digestion 1986;33:17-25.
76. Soudah HC, Lu Y, Hasler WL, Owyang C: Choecystokinin at physiological level evokes pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol 1992;263:G102-G107.
77. Jo YH, Lee YL, Lee KY, Chang TM, Chey WY: Neurohormonal mechanism of pancreatic exocrine secretion stimulated by sodium oleate. Am J Physiol 1992;263:G12-G16.
78. Kim CD, Lee KY, Chang TM, Chey WY: Negative feedback regulation of pancreatic exocrine secretion in guinea pigs. Pancreas 1995; 10:173-179.
79. Li P, Chang TM, Chey WY: Neural regulation of acid-stimulated pancreatic exocrine secretion and release of secretin in rats. Gastroenterology 1997;112:A457.
80. Li P, Chang TM, Chey WY: Neuronal regulation of the release and action of secretin-releasing peptide and secretin. Am J Physiol 1995; 269:G305-G312.
81. Li Y, Owyang C: Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats. Gastroenterology 1994;107:525-531.
82. Li Y, Owyang C: Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest 1993;92:418-424.
83. Jyotheeswaran S, Li P, Chang TM, Chey WY: Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats. Pancreas 2000;20:401-407.
84. Konturek SJ, Blaski J, Konturek PK, Cieszkowski M, Pawlik W: Role of endogenous nitric oxide in the control of canine pancreatic secretion and blood flow. Gastroenterology 1993; 104:896-902.
85. Lee SO, Lee KY, Li P, Coy D, Chang TM, Chey WY: Pituitary adenylate cyclase-activating peptide stimulates rat pancreatic secretion via secretin and cholecystokinin releases. Gastroenterology 1998;114:1054-1060.
86. Chang CH, Chey WY, Braggins L, Coy DH, Chang TM: Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells. Am J Physiol 1996;271: G516-G523.
87. Chang CH, Chey WY, Erway BE, Coy DH, Chang TM: Modulation of secretin release by neuropeptides in secretin-producing cells. Am J Physiol 1998;275:G192-G202.
88. Yada T, Sakurada M, Ihida K, Nakata M, Murata M, Arimura A, Kikuchi M: Pituitary adenylate cyclase activating polypeptide is an extraordinary potent intrapancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem 1994;269:1290-1293.
89. Glad H, Svendsen P, Ainsworth MA, Olsen O, Rehfeld JF, Schaffalitzky de Muckadell OB: The effect of gastrin-releasing peptide on porcine pancreaticobiliary bicarbonate secretion is mediated by secretin. Scand J Gastroenterol 1994;29:195-202.
90. Li P, Chang TM, Coy D, Chey WY: Gastrinreleasing peptide stimulates release of secretin in anesthetized rats. Gastroenterology 1995; 108:A985.
91. Miyata M, Guzman SB, Rayford PL, Thompson JC: Response to cholecystokinin, secretin and pancreatic secretion to graded doses of bombesin. Surg Forum 1978;29:390-392.
92. Jansen JBMJ, Lamers CBHW: Molecular form of cholecystokinin in human plasma during infusion of bombesin. Life Sci 1983;33:2197-2205.
93. Glad H, Svendsen P, Knuhsten S, Olsen O, Schaffalitzky de Muckadell OB: Importance of gastrin-releasing peptide on acid-induced secretin release and pancreaticobiliary and duodenal bicarbonate secretion. Scand J Gastroenterol 1996;31:993-1000.
94. Herzig KH, Louie DS, Owyang C: In vivo action of bombesin on exocrine pancreatic secretion in the rat: Independent of cholecystokinin and cholinergic mediation. Pancreas 1988;3:292-296.
95. Park HS, Kwon HY, Lee YL, Chey WY, Park HJ: Role of GRPergic neurons in secretin-evoked exocrine secretion in isolated rat pancreas. Am J Physiol Gastrointest Liver Physiol 2000;278:G557-G562.
96. Flowe KM, Welling TH, Mulholland WM: Gastrin-releasing peptide stimulation of amylase release from rat pancreatic lobules involves intrapancreatic neurons. Pancreas 1994;9:513-517.
97. Horstmann O, Nustede R, Schmidt W, Stockmann F, Becker H: On the role of gastrin-releasing peptide in meal-stimulated exocrine pancreatic secretion. Pancreas 1999;19:126-132.
98. Singer MV, Solomon TE, Wood J, Grossman MI: Latency of pancreatic enzyme response to intraduodenal stimulants. Am J Physiol 1980;238:G23-G29.
99. Kirchgessner AL, Pintar JE: Guinea pig pancreatic ganglia: Projections, transmitter content, and the type-specific localization of monoamine oxidase. J Comp Neurol 1991; 305:613-631.
100. 1P receptors. J Comp Neurol 1993;327:233-250.
101. Adeghate E, Ponery AS, Pallot D, Parvez SH, Singh J: Distribution of serotonin and its effect on insulin and glucagon secretion in normal and diabetic pancreatic tissues in rat. Neurobiol Lett 1999;20:315-322.
102. Suzuki A, Ishiguro H, Naruse S: Effects of 5-hydroxytryptamine on fluid secretion in guinea-pig pancreatic duct cells. J Physiol Lond 2000;527P:41P.
103. Zhu JX, Zhu XY, Owyang C, Li Y: Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol Lond 2001;530:431-442.
104. Funita T: Insulo-acinar portal system in the horse pancreas. Arch Histol Jpn 1973;35: 161-171.
105. Henderson J, Daniel AA: Comparative study of the portal vessels connecting the endocrine and exocrine pancreas; with a discussion of some functional implications. Q J Exp Physiol 1979;64:267-275.
106. Williams JA, Goldfine I: The insulin-pancreatic acinar axis. Diabetes 1985;34:980-986.
107. Kanno T, Saito A: The potentiating influences of insulin on pancreozymin-induced hyperpolarization and amylase release in the pancreatic acinar cell. J Physiol Lond 1976; 261:505-521.
108. Saito A, Williams JA, Kanno T: Potentiation of cholecystokinin-induced exocrine secretion by both exogenous and endogenous insulin in isolated and perfused rat pancreas. J Clin Invest 1980;65:777-782.
109. Saito A, Williams JA, Kanno T: Potentiation by insulin of the acetylcholine-induced secretory response of the perfused rat pancreas. Biomed Res 1980;1:101-103.
110. Lee KY, Lee YL, Kim CD, Chang TM, Chey WY: Mechanism of the action of insulin on pancreatic exocrine secretion in perfused rat pancreas. Am J Physiol 1994;267:G207-G212.
111. Lee KY, Krusch D, Zhou L, Song Y, Chang TM, Chey WY: Effect of endogenous insulin on pancreatic exocrine secretion in perfused dog pancreas. Pancreas 1995;11:190-195.
112. Chey WY: Hormonal control of pancreatic exocrine secretion; in Go, VLW et al. (eds): The Pancreas: Biology, Pathobiology, and Disease, ed 2. New York, Raven Press, 1993, pp 403-424.
113. Folsch UR, Cantor P, Wilms HM, Schafmayer A, Becker HD, Creutzfeldt W: Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology 1987;92:449-458.
114. Liddle RA, Goldfine ID, Williams JA: Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin and alcohol. Gastroenterology 1984;87:542-549.
115. Louie DS, May D, Miller P, Owyang C: Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Am J Physiol 1986;250:G252-G259.
116. Shiratori K, Chen YF, Chey WY, Lee KY, Chang TM: Mechanism of increased exocrine pancreatic secretion in pancreatic juice-diverted rats. Gastroenterology 1986;91:1171-1178.
117. Imamura M, Lee KY, Chang TM, Chey WY: Role of secretin in negative feedback regulation of postprandial pancreatic secretion in dogs. Gastroenterology 1993;105:548-553.
118. Kim CD, Lee KY, Chang TM, Chey WY: Negative feedback regulation of pancreatic exocrine secretion in guinea pigs. Pancreas 1995;10:173-179.
119. Sun G, Lee KY, Chang TM, Chey WY: Effect of pancreatic juice diversion on secretin release in rats. Gastroenterology 1989;96: 1173-1179.
120. Shiratori K, Jo YH, Lee KY, Chang TM, Chey WY: Effect of pancreatic juice and trypsin on oleic acid-stimulated pancreatic secretion and plasma secretin in dogs. Gastroenterology 1989;96:1330-1336.
121. Nustede R, Kohler H, Peiper M, Felmelden D, Folsch UR, Schafmayer A: Contribution of neurotensin to the entero-pancreatic axis. Digestion 1990;46(suppl 2):188-194.
122. Guan D, Maouyo D, Taylor IL, Gettys TW, Greeley GH, Morisset J: Peptide-YY, a new partner in the negative feedback control of pancreatic secretion. Endocrinology 1991; 128:911-916.
123. Lu L, Louie D, Owyang C: A cholecystokinin-releasing peptide mediates feedbeck regulation of pancreatic secretion. Am J Physiol 1989;256:G430-G435.
124. Miyasaka K Guan D, Liddle RA, Green GM: Feedback regulation by trypsin: Evidence for intraluminal CCK-releasing peptide. Am J Physiol 1989;257:G175-G181.
125. Li P, Lee KY, Chang TM, Chey WY: Mechanism of acid-induced release of secretin in rats: Presence of a secretin releasing factor. J Clin Invest 1990;86:1474-1479.
126. Iwai K, Fukuoka S, Fushiki T, Tsujikawa M, Hirose M, Tsunasawa S, Sakiyama F: Purification of a trypsin-sensitive cholecystokinin-releasing peptide from pancreatic juice. J Biol Chem 1987;262:8956-8959.
127. Iwai K, Fukuoka T, Fushiki T, Koraira T, Ikei N: Elevation of plasma CCK concentration after intestinal administration of a pancreatic enzyme secretion-stimulating peptide purified from rat bile-pancreatic juice: Analysis with N-terminal region-specific radioimmunoassay. Biochem Biophys Res Commun 1986;136:701-706.
128. Bouras EP, Misukonis MA, Liddle RA: Role of calcium in monitor peptide-stimulated cholecystokinin release from perifused intestinal cells. Am J Physiol 1992;262:G791-G796.
129. Liddle RA, Misukonis MA, Pacy L, Balber AE: Cholecystokinin cells purified by fluorescence-activated cell sorting respond to monitor peptide with an increase in intracellular calcium. Proc Natl Acad Sci USA 1992;89: 5147-5151.
130. Li P, Song Y, Lee KY, Chang TM, Chey WY: A secretin-releasing peptide exists in dog pancreatic juice. Life Sci 2000;66:1307-1316.
131. Song Y, Li P, Lee KY, Chang TM, Chey WY: Canine pancreatic juice stimulates the release of secretin and pancreatic secretion in the dog. Am J Physiol 1999;277:G731-G735.
132. Spannagel AW, Green GM, Guan D, Liddle RA, Faull K, Reeve JR Jr: Purification and characterization of luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc Natl Acad Sci USA 1996;93:4415-4420.
133. Spannagel AW, Reeve JR Jr, Liddle RA, Guan D, Green GM: An amino-terminal fragment of LCRF, LCRF(1-35), has the same activity as the natural peptide. Am J Physiol 1997;273:G754-G758.
134. Spannagel AW, Reeve JR Jr, Greeley GH Jr, Yanaihara N, Liddle RA, Green GM: Bioactivity of intraduodenally and intravenously infused fragments of luminal cholecystokinin releasing factor. Regul Pept 1998;73:161-164.
135. Herzig KH, Schon I, Tatemoto K, Ohe Y, Li Y, Folsch UR, Owyang C: Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc Natl Acad Sci USA 1996;93:7927-7932.
136. Chen ZW, Agerberth B, Gell K, Andersson M, Mutt V, Ostenson CG, Efendic S, Barros-Soderling J, Persson B, Jornvall H: Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem 1988;174:239-245.
137. Herzig KH, Wilgus C, Schon I, Tatemoto K, Folsch UR: Regulation of the action of the novel cholecystokinin-releasing peptide diazepam-binding inhibitor by inhibitory hormones and taurocholate. Regul Pept 1998;74: 193-198.
138. Li Y, Hao Y, Owyang C: Diazepam binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin. J Clin Invest 2000;105: 351-359.
139. 2 from canine pancreatic juice. Pancreas 1999;19:401-405.
140. 2 stimulates secretin release from secretin-producing cells. J Biol Chem 1999;274:10758-10764.
141. 2 from the small intestine is a secretin-releasing factor in the rat. Am J Physiol 2001, in press.
142. Li JP, Lee KY, Chang TM, Chey WY: MEK inhibits secretin release and pancreatic secretion: Roles of secretin-releasing peptide and somatostatin. Am J Physiol Gastrointest Liver Physiol 2001;280:G890-G896.
143. Herzig KH, Louie DS, Owyang C: Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide. Am J Physiol 1994;266:G1156-G1161.
144. Li Y, Owyang C: Peptone stimulates CCK-releasing peptide secretion by activating intestinal submucosal cholinergic neurons. J Clin Invest 1996;97:1463-1470.
145. Chey WY: Neurohormonal control of the exocrine pancreas. Curr Opin Gastroenterol 1995;11:389-396.